Exane Derivatives Acelrx Pharmaceuticals Inc Transaction History

Exane Derivatives

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$0.18 - $0.29 $0 - $0	-1 Closed	0 $0
Q2 2021 Jul 28, 2021	SELL	$1.03 - $1.7 $66,694 - $110,078	-64,752 Reduced 100.0%	1 $0
Q1 2021 Apr 30, 2021	BUY	$1.25 - $2.77 $80,941 - $179,365	64,753 New	64,753 $110,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

Stay updated on Exane Derivatives with notifications on news.